STAT1 modification improves therapeutic effects of interferons on lung cancer cells

BACKGROUND: Interferons (IFNs) have potent anti-proliferative, pro-apoptotic, and immunomodulatory activities against cancer. However, the clinical utility of IFNs is limited by toxicity and pharmacokinetics making it difficult to achieve sustained therapeutic levels especially in solid tumors. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Junjie, Zhao, Jialu, Chen, Lefu, Dong, Nian, Ying, Zhaojian, Cai, Zhenzhen, Ji, Dongxiang, Zhang, Yong, Dong, Li, Li, Yuping, Jiang, Lei, Holtzman, Michael J., Chen, Chengshui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562290/
https://www.ncbi.nlm.nih.gov/pubmed/26351076
http://dx.doi.org/10.1186/s12967-015-0656-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562290/
https://www.ncbi.nlm.nih.gov/pubmed/26351076
http://dx.doi.org/10.1186/s12967-015-0656-0

Ejemplares similares